(NYSE: NVRO) Nevro's forecast annual revenue growth rate of 15.64% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.6%.
Nevro's revenue in 2023 is $395,281,000.On average, 6 Wall Street analysts forecast NVRO's revenue for 2023 to be $16,195,341,693, with the lowest NVRO revenue forecast at $15,730,959,516, and the highest NVRO revenue forecast at $16,644,878,662.
In 2024, NVRO is forecast to generate $18,156,149,108 in revenue, with the lowest revenue forecast at $17,434,438,195 and the highest revenue forecast at $18,816,211,666.